Rhythm Pharmaceuticals Inc (RYTM)
38.90
+0.79
(+2.07%)
USD |
NASDAQ |
Apr 19, 09:57
Rhythm Pharmaceuticals Max Drawdown (5Y): 92.10% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 92.10% |
| February 29, 2024 | 92.10% |
| January 31, 2024 | 92.10% |
| December 31, 2023 | 92.10% |
| November 30, 2023 | 92.10% |
| October 31, 2023 | 92.10% |
| September 30, 2023 | 92.10% |
| August 31, 2023 | 92.10% |
| July 31, 2023 | 92.10% |
| June 30, 2023 | 92.10% |
| May 31, 2023 | 92.10% |
| April 30, 2023 | 92.10% |
| March 31, 2023 | 92.10% |
| February 28, 2023 | 92.10% |
| January 31, 2023 | 92.10% |
| December 31, 2022 | 92.10% |
| November 30, 2022 | 92.10% |
| October 31, 2022 | 92.10% |
| September 30, 2022 | 92.10% |
| August 31, 2022 | 92.10% |
| July 31, 2022 | 92.10% |
| June 30, 2022 | 92.10% |
| May 31, 2022 | 92.10% |
| April 30, 2022 | 84.48% |
| March 31, 2022 | 84.48% |
| Date | Value |
|---|---|
| February 28, 2022 | 84.48% |
| January 31, 2022 | 82.91% |
| December 31, 2021 | 78.17% |
| November 30, 2021 | 77.59% |
| October 31, 2021 | 72.37% |
| September 30, 2021 | 70.42% |
| August 31, 2021 | 70.42% |
| July 31, 2021 | 63.29% |
| June 30, 2021 | 63.29% |
| May 31, 2021 | 63.29% |
| April 30, 2021 | 63.29% |
| March 31, 2021 | 63.29% |
| February 28, 2021 | 63.29% |
| January 31, 2021 | 63.29% |
| December 31, 2020 | 63.29% |
| November 30, 2020 | 63.29% |
| October 31, 2020 | 63.29% |
| September 30, 2020 | 63.29% |
| August 31, 2020 | 63.29% |
| July 31, 2020 | 63.29% |
| June 30, 2020 | 63.29% |
| May 31, 2020 | 63.29% |
| April 30, 2020 | 63.29% |
| March 31, 2020 | 63.29% |
| February 29, 2020 | 51.49% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
47.22%
Minimum
Apr 2019
92.10%
Maximum
May 2022
73.86%
Average
71.40%
Median
Max Drawdown (5Y) Benchmarks
| Pfizer Inc | 53.93% |
| Insmed Inc | 63.30% |
| Altimmune Inc | 99.85% |
| Regeneron Pharmaceuticals Inc | 53.84% |
| Viking Therapeutics Inc | 89.26% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -17.19 |
| Beta (5Y) | 1.898 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 143.1% |
| Historical Sharpe Ratio (5Y) | 0.0531 |
| Historical Sortino (5Y) | 0.1781 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.83% |